Australian software developer Cybec Pty. Ltd. has sold Vet, its antivirus business, to Computer Associates International Inc. (CA) for an undisclosed amount.
The acquisition gives CA access to Vet's existing base of more than one million Australian users, including Westpac and St George Bank, said Chris Morison, Vet's CEO.
CA would continue to offer Vet as a standalone product as well as integrating the technology into its existing product line, said John Ruthven, CA Australia's managing director.
CA claims its existing antivirus product line, including InoculateIT, is among the top three in the world.
Vet's antivirus products cover home, office and enterprise applications, and it also has a security offering.
Cybec's local antivirus market share is around 30 percent, Morison said, with up to 50 percent in the retail and SOHO (small office, home office) arenas. Vet has a small share of the corporate market, which is set to expand with assistance from Computer Associates.
The sale also includes Cybec's virus research facility in Melbourne, which will join CA's global research centers. All Vet staff have been offered positions with Computer Associates.
The purchase comes in the wake of Vet's best ever first-half financial results, Morison said.
Roger Riordan, Cybec founder, would not reveal to ComputerWorld Today how much the sale was worth, but did say he and his staff had "done very well out of the sale."
"My wife says we'll never have to fly cattle class (economy) again," he said. "And we can probably do a lot of flying."